Is ARVN or ASBP more undervalued in 2026?

CirclFi compares Arvinas, Inc. (ARVN) and Aspire Biopharma Holdings, Inc. (ASBP) using 13 institutional-grade valuation models. ARVN has a Quality of Company score of 6.9/10 while ASBP scores 4.6/10.

Which is a better buy — ARVN or ASBP?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ARVN and ASBP valuations compare?

ARVN at $8.84 and ASBP at $5.53 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ARVN vs ASBP Valuation Comparison 2026 — Intrinsic Value Analysis

ARVN

Biotechnology

Arvinas, Inc.

Quality

6.9

out of 10

Value Trap

SAFE

Price

$8.84

Last close

Models

10/13

Active

ASBP

Biotechnology

Aspire Biopharma Holdings, Inc.

Quality

4.6

out of 10

Value Trap

SAFE

Price

$5.53

Last close

Models

8/13

Active

Model-by-Model Comparison

Model	Type	ARVN Fair Value	ARVN Upside	ASBP Fair Value	ASBP Upside
Bayesian DCF	Intrinsic	$2.43	-72.5%	$3.92	-29.0%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$1.47	-83.8%	$0.01	-95.5%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$12.09	+36.8%	$7.61	+37.6%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ARVN vs ASBP — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ARVN vs ASBP — Which Stock Is More Undervalued?

ARVN scores higher with a 6.9/10 quality rating vs ASBP's 4.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Arvinas, Inc. (ARVN) and Aspire Biopharma Holdings, Inc. (ASBP) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ARVN currently trades at $8.84 with a QOC of 6.9/10, while ASBP trades at $5.53 with a QOC of 4.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).